132 related articles for article (PubMed ID: 8165439)
1. Association of anti-U1RNP- and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma).
Hietarinta M; Lassila O; Hietaharju A
Scand J Rheumatol; 1994; 23(2):64-7. PubMed ID: 8165439
[TBL] [Abstract][Full Text] [Related]
2. Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia.
Herrick AL; Heaney M; Hollis S; Jayson MI
Ann Rheum Dis; 1994 Aug; 53(8):540-2. PubMed ID: 7944641
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA antigens with anti-Scl-70-antibodies and clinical manifestations of systemic sclerosis (scleroderma).
Hietarinta M; Ilonen J; Lassila O; Hietaharju A
Br J Rheumatol; 1994 Apr; 33(4):323-6. PubMed ID: 8156302
[TBL] [Abstract][Full Text] [Related]
4. Anti-U1RNP antibodies in patients with localized scieroderma.
Yamane K; Ihn H; Kubo M; Kuwana M; Asano Y; Yazawa N; Tamaki K
Arch Dermatol Res; 2001 Sep; 293(9):455-9. PubMed ID: 11758788
[TBL] [Abstract][Full Text] [Related]
5. Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis.
Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Sato S; Kikuchi K; Tamaki K
Clin Exp Immunol; 1999 Aug; 117(2):383-7. PubMed ID: 10444274
[TBL] [Abstract][Full Text] [Related]
6. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.
Satoh M; Vazquez-Del Mercado M; Krzyszczak ME; Li Y; Ceribelli A; Burlingame RW; Webb TT; Sobel ES; Reeves WH; Chan EK
Lupus; 2012 Jan; 21(1):68-74. PubMed ID: 22025191
[TBL] [Abstract][Full Text] [Related]
8. Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.
Chevalier K; Chassagnon G; Leonard-Louis S; Cohen P; Dunogue B; Regent A; Thoreau B; Mouthon L; Chaigne B
J Autoimmun; 2024 Jun; 146():103220. PubMed ID: 38642508
[TBL] [Abstract][Full Text] [Related]
9. Scleroderma: DR antigens, autoantibodies and clinical manifestations.
Alarcón GS; McCarty GA; Lanyon P; Phillips RM; Acton RT; Barger BO
Clin Exp Rheumatol; 1987; 5(4):317-21. PubMed ID: 3326691
[TBL] [Abstract][Full Text] [Related]
10. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study.
Valenzuela A; Baron M; ; Herrick AL; Proudman S; Stevens W; ; Rodriguez-Reyna TS; Vacca A; Medsger TA; Hinchcliff M; Hsu V; Wu JY; Fiorentino D; Chung L
Semin Arthritis Rheum; 2016 Dec; 46(3):344-349. PubMed ID: 27371996
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil.
Skare TL; Fonseca AE; Luciano AC; Azevedo PM
An Bras Dermatol; 2011; 86(6):1075-81. PubMed ID: 22281893
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system.
López-Longo FJ; Rodríguez-Mahou M; Escalona-Monge M; González CM; Monteagudo I; Carreño-Pérez L
Lupus; 2003; 12(8):623-9. PubMed ID: 12945722
[TBL] [Abstract][Full Text] [Related]
13. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of patients with both anti-U1RNP and anti-centromere antibodies.
Takada K; Suzuki K; Matsumoto M; Okada M; Nakanishi T; Horikoshi H; Higuchi T; Ohsuzu F
Scand J Rheumatol; 2008; 37(5):360-4. PubMed ID: 18686191
[TBL] [Abstract][Full Text] [Related]
15. [Anti-Scl-70 antibody and anti-nucleolar antibody in patients with systemic sclerosis].
Kinoshita M
Nihon Rinsho; 1990 Feb; 48 Suppl():494-6. PubMed ID: 2355569
[No Abstract] [Full Text] [Related]
16. Two sisters producing anti-U1RNP exhibit serological concordance and clinical discordance.
Reichlin M; Abumohor P; Itoh Y
Lupus; 1992 Aug; 1(4):249-54. PubMed ID: 1301988
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of 151 patients with high-titer U1RNP antibodies.
Frandsen PB; Kriegbaum NJ; Ullman S; Høier-Madsen M; Wiik A; Halberg P
Clin Rheumatol; 1996 May; 15(3):254-60. PubMed ID: 8793256
[TBL] [Abstract][Full Text] [Related]
18. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
[TBL] [Abstract][Full Text] [Related]
19. [Anti-U1RNP antibodies and lupus nephritis].
Ilić T; Curić S; Vodopivec S; Mitić I; Durdević-Mirković T; Sakac V; Lenert P
Med Pregl; 2000; 53(11-12):589-94. PubMed ID: 11320745
[TBL] [Abstract][Full Text] [Related]
20. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients.
Furtado RN; Pucinelli ML; Cristo VV; Andrade LE; Sato EI
Lupus; 2002; 11(1):35-41. PubMed ID: 11899953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
